Iranian Journal of Pathology

Clinical Validation of Eleven Formulas for Calculating LDL-C in Iran

Document Type : Original Research

Authors

Fereshteh Atabi 1
Reza Mohammadi 2

1 Department of Biochemistry and Biophysics, Faculty of Advanced Sciences and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran

2 Department of Biochemistry, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran

https://doi.org/10.30699/ijp.2020.110379.2174
Abstract
Background & Objective:
Concentration of low-density lipoprotein (LDL) is a known risk factor for cardiovascular disease which is routinely measured or calculated as LDL-C in clinical laboratories. In order to decrease the cost, instead of its measuring, it is recommended to calculate it using multiple formulas that have been introduced up to now. The aim of this study was to assess the results of various formulas and comparison of these results with those of measuring method and to clarify the best formula for the Iranian population.
Methods:
Concentrations of total cholesterol (TC), triglyceride (TG), cholesterol of high-density lipoprotein (HDL-C) and LDL-C in serums of 471 overnight fasting individuals were measured and also LDL-Cs of these samples were calculated by eleven different formulas according to their TC, TG, and HDL-C concentrations. Subsequently, results of measured and calculated LDL-C were analyzed statistically by paired t-test, correlation coefficient, and Passing-Bablok regression. In addition, for clinical evaluation, the differences between calculated and measured mean results were calculated and compared with an allowable total error.
Result:
Paired t-test unraveled a significant difference between the results of measured and calculated LDL-C by various formulas. But for some formulas, these differences were not clinically significant. The best clinical and statistical agreement (correlation coefficient) was obtained by the Friedewald equation.
Conclusion:
By using validated methods which have correct calibration and control system for measuring TC, TG, and HDL-C, we can use the Friedewald formula for calculating LDL-C in serum samples with TG up to 400 mg/dL.

Highlights

✅By using validated methods which have correct calibration and control system for measuring TC, TG, and HDL-C, we can use the Friedewald formula for calculating LDL-C in serum samples with TG up to 400 mg/dL.

Keywords

Cardiovascular disease
LDL
Friedewald formula
HDL
TG

Subjects

Introduction

Cardiovascular disease is the most common cause of morbidity and mortality worldwide (1). Increased plasma low density lipoprotein (LDL) concentration is an important known risk factor for this disease (2-4). So, one of the main goals in preventing cardiovascular disease is to reduce plasma or serum LDL concentration (1,3). Ultracentrifugation is the reference method for measuring serum LDL concentration and LDL subfraction distribution which is cumbersome and has a high cost (4,5). Therefore, Ultracentrifugation is not common in routine clinical laboratories (1). Some clinical laboratories measure cholesterol component of LDL (LDL-C) as an estimate of LDL concentration. These homogenous direct LDL-C methods rely on measuring cholesterol of LDL particles in the presence of other lipoprotein particles which have been prevented from participating in measuring cholesterol reaction. In the third method, LDL-C is calculated according to the total cholesterol (TC), triglyceride (TG), cholesterol of high density lipoprotein (HDL-C) and LDL-C and applying Friedewald equation (6).
Although LDL-C homogenous direct methods are precise and can be used in autoanalyzer instruments, in some cases, such as presence of abnormal lipoproteins, they have differences in ultracentrifugation methods. When triglyceride concentration is lower than 400 mg/dL, using direct method has no advantages to the calculation method. On the other hand, calculation method is associated with decreasing the cost. National Cholesterol Education Program- Adult treatment panel III (NCEP-ATP III) recommends to use calculated LDL-C, instead of LDL-C direct methods, for serum samples with TG concentration up to 400 mg/dL. According to this recommendation, running of direct LDL-C would only enhance the expense (3,7). Friedewald equation is based on four assumptions: 1) In 12 hours overnight fasting state, chylomicron is not presented in circulation and total plasma cholesterol concentration is primarily carried in VLDL, LDL, and HDL forms; 2) Essentially all plasma TG are carried by VLDL; 3) VLDL-TG /cholesterol ratio is constant; and 4) Cholesterol concentration of VLDL (VLDL-C) is one fifth of TG concentration (7). According to these assumptions, Friedewald equation is as LDL-C = Tc – (HDL-C + TG/5) (8). In this equation, units of all analysts are according to mg/dL.
In spite of extensive application of Friedewald equation for calculating LDL-C concentration of serum samples with TG up to 400 mg/dL, several studies have shown that this equation lack good performance in various conditions (1,2,8-14). Thereby, multiple groups are continuously evaluating the Friedewald equation accuracy in different population and diseases (1,3). According to these studies, more than ten equations were introduced for calculating LDL-C.
The aim of this study was to compare results of calculating LDL-C by eleven introduced equations, including Friedewald equation, with results of direct LDL-C measuring method and determining the best equation for Iranian population. In this study, we also compared the results of statistical analysis and clinical requirements which are necessary for validating methods in clinical laboratories.


 

Materials and Methods

Grouping
The accuracy of LDL-C calculation is affected by TG concentration. Errors in LDL-C calculation become noticeable in triglyceride concentrations over 200 mg/dL and become unacceptably large at triglyceride concentrations over 400 mg/dL. On the other hand, as Friedewald equation is valid only for samples with TG concentrations up to 400 mg/d, 29 samples with TG concentrations more than 400 mg/dL were excluded and 471 remained samples were classified in four groups with TG concentrations up to 100 mg/dL, 101 to 200 mg/dL, 201 to 300 mg/dL, and 301 to 400 mg/dL, which their sample numbers were 185, 204, 70, and 12, respectively.      

Study Population
Study population included 500 staffs of Ava Protein Company, a meat and poultry Products Company in Tehran, Iran, which during November 2018 participated in annual health screening. Venous blood samples of these individuals were collected in redtop vacuum tubes containing coagulation accelerator and gel separator after 12 to 14 hours overnight fasting (5). Serums were separated within 2 hours by centrifugation of coagulated whole bloods at 500 g for 10 minutes. Then separated serums were transported into disposable tubes and refrigerated.

Lipid Profile Analyses
Lipid profile, including TC, TG, HDL-C, and LDL-C, were analyzed daily within 6 hours after blood collection. We used Pars Azmoon kits for lipid analyses, which are the common biochemical kits in Iran. For measuring serum total cholesterol by Pars Azmoon kit, cholesteryl esters are hydrolyzed by cholesteryl esterase and then 3-OH group of cholesterol is oxidized and finally hydrogen peroxide produced by this reaction is quantified by producing colored product during peroxidase reaction. Principle of measuring of serum triglyceride by Pars Azmoon kit is as principle of cholesterol measuring, except that glycerol is produced by action of lipase on triglyceride and hydrogen peroxide is produced during glycerol oxidase reaction. For measuring serum LDL-C and HDL-C, Pars Azmoon kits use direct methods in which blocking agents inhibit lipoproteins other than LDL-C and HDL-C to participate in cholesterol measurement, respectively.
Pars Azmoon kits were installed on Roche Hitachi 912 Chemistry Analyzer and calibrated by calibrator recommended by kit producer. For calibration assurance, calibration verification was accomplished daily. Also for assurance of accurate performance of the methods, two level quality control (QC) materials, including normal and high concentration levels, were used in each run and the results of QC materials were interpreted according to sigma metrics.

LDL-C Calculation
In order to calculate LDL-C, we used eleven equations which are listed in Table 1.

Table 1. Formulas which were used to calculate LDL-C.

Formula Equation Reference
Friedewald LDL-C  =  TC – HDL-C – (TG/5) 6, 9, 10
Puavilai LDL-C  =  TC – HDL-C – (TG/6) 10
Vujovic LDL-C  =  TC – HDL-C – (TG/6.85) 10
Hattori LDL-C  =  (0.94 × TC) – (0.94 × HDL-C) – (0.19 × TG) 6, 9, 10
Anandaraja LDL-C  =  (0.9 × TC) – (0. 9 × [TG/5]) – 28 6, 9, 10
Chen LDL-C  =  (0.9 × TC) – (0.9 × HDL-C) – (0.1 × TG) 6, 10
Cordova LDL-C  =  0.7516 × (TC – HDL-C) 6
Teerakanchana LDL-C  =  (0.91 × TC) – (0.634 × HDL-C) – (0.111 × TG) – 6.755 6, 9
Ahmadi LDL-C  =  (TC/1.19) – (HDL-C/1.1) – (TG/1.9) - 38 6, 9
DeLong LDL-C  =  TC – HDL-C – (0.16 × TG) 9
Rao LDL-C  =  [(4.7 × TC) – (4.364 × HDL-C) –TG]/4.487 9
Abbreviations: HDL-C, High density lipoprotein cholesterol; LDL-C, Low density lipoprotein cholesterol; TC, Total cholesterol; TG, Triglyceride.

Data Analyses
Data were analyzed both statistically and clinically. For statistical analyses, we used Paired t-test, correlation coefficient, and Passing-Bablok regression. Linear regression is not valid, as both comparative methods (direct measured LDL-C) and test method (calculated LDL-C) have errors. MedCalc software was used for statistical analyses.
For clinical analyses of acceptable performance of measuring methods, we used total allowable error (TEa) of 12% which is determined by NCEP (15). This TEa is for when the test is repeated once. In this situation, one third of TEa is considered for systematic error (bias) (15), two third for random error (imprecision), and, when the t-test is repeated, imprecision is decreased by (16) which itself results in decreasing TEa to modify TEa (mTEa) calculated as equation (1-1): 

                                                                                                                                
When the test is repeated or samples are 400 or more, random error decreases to 5% or lower and we can ignore this error. In this case, TEa reduces to bias (one third of 12%) which equals 4%. In this study, when we divided 471 samples in four groups, numbers of samples in groups 1 to group 4 were 185, 204, 70, and 12. So, calculated mTEa for these groups are 4.6%, 4.6%, 5.0%, and 6.3%, respectively.
 

 

Results

Of the CCC samples, 15 were ECCC and 27 samples were OCCC. Of the 42 non-CCC, 22 were endometrioid, 2 were papillary serous carcinoma of endometrium, 6 were endometrioid and 12 were HGSC of ovary. Mean age of the patients in CCC and non-CCC groups were 52.1 years and 57.3 years respectively (P=0.08). Other clinicopathologic features including pathologic stage, myometrial invasion, ovarian

Mean of results of calculating LDL-C by different formulas along with the results of statistical (paired t-test) and clinically (TEa 4% for more than 400 samples) comparison of these mean values with mean values of measured LDL-C, are summarized in Table 2. There was statistically a significant difference (P<0.0001) between calculated mean values and measured mean value. This difference was also clinically significant for all calculations, except Friedewald, Anandaraja, and Chen formulas.

Table 2. Statistic and clinical comparison of calculated LDL-C mean values of different formulas with measured LDL-C mean value (104.52 mg/dL; 95% CI from 101.52 to 107.10 mg/dL).

Formula Mean Paired t-test Difference
Value 95% CI Statistic TTP Absolute Percent CS
Friedewald 106.57 103.93 to 109.21 6.051 < 0.0001 2.05 2.0 No
Puavilai 110.97 108.30 to 113.64 18.568 < 0.0001 6.45 6.2 Yes
Vujovic 113.70 116.39 to 111.00 24.860 < 0.0001 9.18 8.8 Yes
Hattori 99.1 102.40 to 97.43 - 13.846 < 0.0001 -4.61 -4.4 Yes
Anandaraja 107.88 110.51 to 105.25 6.557 < 0.0001 3.36 3.2 No
Chen 106.47 103.10 to 108.94 4.844 < 0.0001 1.95 1.9 No
Cordova 100.25 97.96 to 102.53 - 7.006 < 0.0001 - 4.27 -4.1 Yes
Teerakanchana 111.85 109.33 to 114.36 19.908 < 0.0001 7.33 7.0 Yes
Ahmadi 118.60 116.09 to 121.12 38.060 < 0.0001 14.08 13.5 Yes
DeLong 111.85 109.17 to 114.52 20.757 < 0.0001 7.33 7.0 Yes
Rao 113.19 110.41 to 114.98 23.421 < 0.0001 8.67 8.3 Yes
Abbreviations: CI, Confidence interval; CS; Clinical significance; LDL-C, Low density lipoprotein cholesterol; TTP; Two-tailed probability.

Results of regression analyses of measured and calculated LDL-C values are summarized in Table 3 and shown in Figure 1. All calculated results exhibited good correlation (>0.9500) with measured results, except for Anandaraja and Cordova equations. According to Passing-Bablok regression, results of Friedewald, Puavalai, Hattori, Cordova, DeLong, and Rao equations showed constant (y intercept) systematic error and results of Chen and Vujovic showed both constant and proportional (slope), but results of Anandaraja showed none of these errors.

Table 3. Regression analyses of calculating LDL-C values of different formulas with measured LDL-C values

FormulaCorrelation coefficientPassing-Bablok regression
Value95% CIEquationSignificant difference
Y interceptSlope
Friedewald 0.9677 0.9614 to 0.9729 y = - 0.827 + 1.027 x No Yes
Puavilai 0.9667 0.9602 to 0.9721 y = 2.014 + 1.036 x No Yes
Vujovic 0.9630 0.9558 to 0.9690 y = 3.025 + 1.047 x Yes Yes
Hattori 0.9675 0.9612 to 0.9728 y = - 0.939 + 0.964 x No Yes
Anandaraja 0.9255 0.9114 to 0.9375 y = - 0.175 + 1.026 x No No
Chen 0.9519 0.9426 to 0.9597 y = 4.840 + 0.958 x Yes Yes
Cordova 0.8862 0.8651 to 0.9041 y = 5.335 + 0.882 x No Yes
Teerakanchana 0.9596 0.9518 to 0.9662 y = 8.063 + 0.981 x Yes No
Ahmadi 0.9596 0.9518 to 0.9662 y = 14.815 + 0.981 x Yes No
DeLong 0.9658 0.9591 to 0.9714 y = 2.277 + 1.039 x No Yes
Rao 0.9657 0.9591 to 0.9713 y = 0.3369 + 1.080 x No Yes

 

 

Fig. 1. Passing-Bablok Regression analyses of calculated LDL-C values of different formulas with measured LDL-C values.

 Table 4 depicts grouping of samples according to TG concentrations along with statistical and clinical comparison of Friedewald calculated LDL-C mean values and measured mean values. Selection of Friedewald results in this analysis was due to having a better agreement with results of measured LDL-C (see Tables 2 and 3). Groups 1 and 2 showed clinically significant differences, but the differences were insignificant for groups 3 and 4. There was no statistically significant difference for all four groups.


Table 4. Statistics and clinical comparison of Friedewald calculated LDL-C mean values with measured LDL-C mean values according to TG concentrations

Group TG
(mg/dL)		 n Mean (mg/dL) Paired t-test Diffferences
Calculated Measured statistic TTP SDdiff Ab (%) C S
1 Up to 100 185 97.57 100.46 - 6.666 <0.000.1 5.8984 - 2.89 - 2.9 No
2 101 – 200 204 111.72 113.13 - 2.730 0.0069 7.3643 - 1.41 - 1.2 No
3 201 – 300 70 102.44 104.74 - 1.981 0.0516 9.7414 - 2.30 - 2.2 No
4 301 - 400 12 101.16 99.88 0.419 0.6830 10.5640 1.28 1.3 No
Abbreviations: Ab; Absolute; CS; Clinical significance; LDL-C, Low density lipoprotein cholesterol; SDdiff, Standard deviation of differences; TG, Triglyceride; TTP; Two-tailed probability.
 

 

Discussion

LDL-C measurement is a routine test in the clinical laboratory which is used for assessing the risk of coronary heart disease. For reducing costs, LDL-C measuring is replaced by calculating LDL-C with Friedewald equation and according to the results of measured TC, TG, and HDL-C (3). During recent years, in order to assess the validity of Friedewald equation and introducing new equations, multiple studies have been performed in different countries, including Iran, which have been raised to different results.
In 2008, Ahmadi et al. showed overestimation of LDL-C by Friedewald equation for samples with low TG and high TG concentrations (6). They introduced a new equation for calculating LDL-C (6) which conferred no good agreement with measured LDL-C in their studies (1,3,17). Boshtam et al. performed another study in Iran in 2012. On the basis of this study, they concluded that Friedewald equation overestimate LDL-C concentrations in Iranian population and recommended to measure LDL-C directly (18).
Cordova et al. had a study on Brazilian population and introduced a new formula for estimation of LDL-C in which TG concentration was omitted (2). In 2016, Hichem et al. reported their study on North Africa (Algeria) population in order to highlight the formula that calculate LDL-C more accurately than Friedewald formula on a North Africa (Algeria) population. They used different formulas for LDL-C calculation, including Friedewald, Hattori, Puavilai, Anandaraja, Ahmadi, Vujovic, and Cordova formulas. They found out that Friedewald, Puavilai, and Vujovic formulas have the highest agreement (correlation coefficient of 0.930 to 0.934). They found out that Friedewald and Puavilai calculated mean values had statistically significant differences, but this difference was not statistically significant for the Vujovic calculated mean value. Finally, they concluded that Puavilai formula was the most suitable for North Africa population (19).
In 2019, Karkhaneh et al. reported their study on eight formulas for LDL-C estimation in Iranian subjects with different metabolic healthcare status according to their Fasting blood sugar (FBS), TG, TC, HDL-C, and age. But they didn't find any formula for accurate estimation of LDL-C in all subjects and concluded that Hattori and Cordova formulas could be the best alternatives for LDL-C direct measurement in Iranian population, especially for healthy subjects. It seems that it was not necessary to divide subjects to different groups according to FBS, TC, HDL-C, and age. Because, in a clinical laboratory, TG concentration is considered as the most important factor affecting on calculating LDL-C concentration (20).      
In the Friedewald formula, VLDL-C is calculated as TG/5. In order to have a better estimation of LDL-C, in Vujovic and DeLong formulas, 5 is replaced by 6 and 6.25, respectively (1,19). In 2016, Rim et al. by studying on Korea population concluded that using a variable factor according to TG concentration is a better approach (1).
In our study, none of the studying formulas and factors had a better performance than Friedewald equation. As shown in Tables 2 and 3, the results of Friedewald and Chen Formulas have the least differences (1.9% and 2.0%, respectively) from measured LDL-C results and between these two formulas, correlation of Friedewald formula was better (0.9677) than Chen formula (0.9519). In 2016, Chen et al. reported that Friedewald formula has the best correlation (0.977) in all TG concentrations (17).
There are many other studies that had evaluated different formulas for calculating LDL-C against LDL-C direct measurement. Some studies showed Frieldwald formula as the best one (21-23), some others showed that other formulas are more accurate (24-29). In contrast, Anwar et al, recommended using direct homogeneous assay in clinical laboratories for measuring LDL-C, because there is no uniformity in performance of LDL-C estimation at different TG levels (30).
An important part of discrepancies in results of multiple studies may be due to probable systematic and random errors in measuring TC, TG, HDL-C, and LDL-C concentrations. Additionally, they are due to mode of judgement and interpretation of results of statistical analysis. In most studies, statistical analysis focused on paired t-test, correlation coefficient, and regression analysis. In addition to have a direct correlation with the differences of means, result of t-test has direct and invert relation with numbers of samples and standard deviation of differences (SDdiff), respectively. Groups 1 and 2 in Table 3 showed significant differences between mean calculated and measured values. These differences are not due to great differences of means (22.89 and 1.41, respectively), but is due to having a higher number of samples (185 and 204, respectively) and a lower SDdiff (5.8984 and 7.3643, respectively). In contrast, Groups 3 and 4 that had comparable mean differences (-2.30 and -1.28, respectively), showed insignificant differences. These differences are due to having a lower number of samples (70 and 12, respectively) and a higher SDdiff (9.7414 and 10.5640, respectively). This showed paired t-test is not a suitable criterion for judgement of results of method comparison study in clinical laboratories. Hence, it is better to have a clinical judgement by using total allowable error (TEa) and modified TEa (mTEa). As shown in Table 3, in spite of statistical differences in groups 1 and 2, clinically these differences were not significant.

 
 

Conclusion

On the basis of this study, if validated methods are used for measuring TC, TG, and LDL-C which has the correct calibration plan and are under correct quality control plan, Friedewald formula is the best equation for calculating LDL-C concentration of serum samples with TG concentration up to 400 mg/dL. In this situations, the differences between calculated and measured LDL-C concentrations is not clinically significant and has no effect on medical decision making.

 

Acknowledgements

The authors gratefully acknowledge the support of Ava Protein Company, Rasad Pathobiology and Genetic Laboratory.


 

Conflicts of Interest

The authors confirm that there are no known conflicts of interest associated with this publication, and there has been no significant financial support for this work that could have influenced its outcome.


 
  1. Rim JH, Lee YH, Lee MH, Kim HY, Choi J, Lee BW, Kang ES, Lee HC, Kim JH, Lee SG, Cha BS. Comparison and validation of 10 equations including a novel method for estimation of LDL-cholesterol in a 168,212 Asian population. Med. 2016 Apr;95(14). [DOI:10.1097/MD.0000000000003230] [PMID] [PMCID]
  2. de Cordova CMM, de Cordova MM. A new accurate, simple formula for LDL-cholesterol estimation based on directly measured blood lipids from a large cohort. Ann Clin Biochem. 2013;50(1):13-9. [DOI:10.1258/acb.2012.011259] [PMID]
  3. Onyenekwu CP, Hoffmann M, Smit F, Matsha TE, Erasmus RT. Comparison of LDL-cholesterol estimate using the Friedewald formula and the newly proposed de Cordova formula with a directly measured LDL-cholesterol in a healthy South African population. Ann Clin Biochem. 2014;51(6):672-9. [DOI:10.1177/0004563214520750] [PMID]
  4. Theodoraki TG, Tsoukatos DC, Karabina S-A, Rallidis LS, Papageorgakis NH, Tselepsis AD. LDL subfractions in patients with myocardial infarction: effect of smoking and β-blocker treatment. Ann Clin Biochem. 2000;37(3):313-8. [DOI:10.1258/0004563001899456] [PMID]
  5. Teerakanchana T, Puavilai W, Suriyaprom K, Tungtrongchitr R. Comparative study of LDL-cholesterol levels in Thai patients by the direct method and using the Friedewald formula. Southeast Asian J Trop Med Public Health. 2007;38(3):519.
  6. AHMADI SA, Boroumand M-A, GOUHARI MK, Tajik P, Dibaj S-M. The impact of low serum triglyceride on LDL-cholesterol estimation. Arch Iran Med .2008.
  7. McPherson RA, Pincus MR. Henry's Clinical Diagnosis and Management by Laboratory Methods E-Book: Elsevier Health Sciences; 2017.
  8. Martin SS, Blaha MJ, Elshazly MB, Toth PP, Kwiterovich PO, Blumenthal RS, Jones SR. Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile. Jama. 2013 Nov 20;310(19):2061-8. [DOI:10.1001/jama.2013.280532] [PMID] [PMCID]
  9. Choukem S-P, Manases T, Nda-Mefoo J-P, Dimala CA, Mboue-Djieka Y, Sobngwi E, et al. Validation of the Friedewald formula for the estimation of low density lipoprotein cholesterol in a sub-Saharan African population. Clin Biochem. 2018;53:25-30. [DOI:10.1016/j.clinbiochem.2017.12.008] [PMID]
  10. Tighe DA, Ockene IS, Reed G, Nicolosi R. Calculated low density lipoprotein cholesterol levels frequently underestimate directly measured low density lipoprotein cholesterol determinations in patients with serum triglyceride levels≤ 4.52 mmol/l: An analysis comparing the LipiDirect® magnetic LDL assay with the Friedewald calculation. Clin Chim Act. 2006;365(1-2):236-42. [DOI:10.1016/j.cca.2005.08.026] [PMID]
  11. Choi H, Shim J-S, Lee MH, Yoon YM, Choi DP, Kim HC. Comparison of formulas for calculating low-density lipoprotein cholesterol in general population and high-risk patients with cardiovascular disease. Korean Circ J. 2016;46(5):688-98. [DOI:10.4070/kcj.2016.46.5.688] [PMID] [PMCID]
  12. Bairaktari E, Elisaf M, Tzallas C, Karabina SA, Tselepis AD, Siamopoulos KC, et al. Evaluation of five methods for determining low-density lipoprotein cholesterol (LDL-C) in hemodialysis patients. Clin Biochem. 2001;34(8):593-602. [DOI:10.1016/S0009-9120(01)00274-0]
  13. Tremblay AJ, Morrissette H, Gagné J-M, Bergeron J, Gagné C, Couture P. Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with β-quantification in a large population. Clin Biochem. 2004;37(9):785-90. [DOI:10.1016/j.clinbiochem.2004.03.008] [PMID]
  14. DeLong DM, DeLong ER, Wood PD, Lippel K, Rifkind BM. A comparison of methods for the estimation of plasma low-and very low-density lipoprotein cholesterol: the Lipid Research Clinics Prevalence Study. Jama. 1986 Nov 7;256(17):2372-7. [DOI:10.1001/jama.256.17.2372] [PMID]
  15. Warnick GR, Kimberly MM, Waymack PP, Leary ET, Myers GL. Standardization of measurements for cholesterol, triglycerides, and major lipoproteins. Lab Med. 2008;39(8):481-90. [DOI:10.1309/6UL9RHJH1JFFU4PY]
  16. Mullins E. Statistics for the quality control chemistry laboratory: Royal Soc Chem; 2007.
  17. Chen Y, Zhang X, Pan B, Jin X, Yao H, Chen B, et al. A modified formula for calculating low-density lipoprotein cholesterol values. Lipids Health Dis. 2010 Dec;9(1):1-5.. [DOI:10.1186/1476-511X-9-52] [PMID] [PMCID]
  18. Boshtam M, Ramezani MA, Naderi G, Sarrafzadegan N. Is Friedewald formula a good estimation for low density lipoprotein level in Iranian population? J Res Med Sci. 2012 Jun;17(6):519.
  19. Hichem B, Hanane B, Mouna Z, Radia S. The best formula for estimating the low density lipoprotein cholesterol on a North African population. bioRxiv. 2016 Jan 1:083790. [DOI:10.1101/083790]
  20. Azam Karkhaneh, Molood Bagherieh, Solmaz Sadeghi and Asma Kheirollahi. Evaluation of eight formulas for LDL-Cestimation in Iranian subjects with different metabolic health statuses: Lip Health Dis. 2019; 18:231. [DOI:10.1186/s12944-019-1178-1] [PMID] [PMCID]
  21. Knopfholz J, Disserol CCD, Pierin AJ, Schirr FL, Streisky L, Takito LL, et al. Validation of the friedewald formula in patients with metabolic syndrome. Cholesterol. 2014;2014. [DOI:10.1155/2014/261878] [PMID] [PMCID]
  22. Molavi F, Namazi N, Asadi M, Sanjari M, Motlagh ME, Shafiee G, et al. Comparison common equations for LDL-C calculation with direct assay and developing a novel formula in Iranian children and adolescents: the CASPIAN V study. Lipids in Health and Disease. 2020;19(1):1-8. [DOI:10.1186/s12944-020-01306-7] [PMID] [PMCID]
  23. Krishnaveni P, Gowda VM. Assessing the validity of Friedewald's formula and Anandraja's formula for serum LDL-cholesterol calculation. Journal of clinical and diagnostic research: JCDR. 2015;9(12):BC01. [DOI:10.7860/JCDR/2015/16850.6870] [PMID] [PMCID]
  24. Brownstein AJ, Martin SS. More accurate LDL-C calculation: Externally validated, guideline endorsed. Clinica Chimica Acta. 2020. [DOI:10.1016/j.cca.2020.03.030] [PMID]
  25. Ephraim RK, Acheampong E, Swaray SM, Odame Anto E, Agbodzakey H, Adoba P, et al. Developing a modified low-density lipoprotein (M-LDL-C) Friedewald's equation as a substitute for direct LDL-C measure in a Ghanaian population: a comparative study. Journal of lipids. 2018;2018. [DOI:10.1155/2018/7078409] [PMID] [PMCID]
  26. Martins J, Olorunju SA, Murray L, Pillay TS. Comparison of equations for the calculation of LDL-cholesterol in hospitalized patients. Clinica Chimica Acta. 2015;444:137-42. [DOI:10.1016/j.cca.2015.01.037] [PMID]
  27. Mehta R, Reyes-Rodríguez E, Bello-Chavolla OY, Guerrero-Díaz AC, Vargas-Vázquez A, Cruz-Bautista I, et al. Performance of LDL-C calculated with Martin's formula compared to the Friedewald equation in familial combined hyperlipidemia. Atherosclerosis. 2018;277:204-10. [DOI:10.1016/j.atherosclerosis.2018.06.868] [PMID]
  28. Mendes de Cordova CM, de Santa Helena ET, Galgowski C, Figueira VH, Setter GB, Markus MRP, et al. Evaluation of a new equation for LDL-c estimation and prediction of death by cardiovascular related events in a German population-based study cohort. Scandinavian journal of clinical and laboratory investigation. 2018;78(3):187-96. [DOI:10.1080/00365513.2018.1432070] [PMID]
  29. Rasouli M, Mokhtari H. Calculation of LDL‐Cholesterol vs. Direct Homogenous Assay. Journal of clinical laboratory analysis. 2017;31(3):e22057. [DOI:10.1002/jcla.22057] [PMID] [PMCID]
  30. Anwar M, Khan DA, Khan FA. Comparison of Friedewald formula and modified Friedewald formula with direct homogeneous assay for low density lipoprotein cholesterol estimation. J Coll Physicians Surg Pak. 2014;24(1):8-12.

 

 

Iranian Journal of Pathology
Volume 15, Issue 4
Autumn 2020
Pages 261-267

  • Receive Date 07 August 2019
  • Revise Date 19 February 2020
  • Accept Date 18 July 2020

Home

Guide for Authors

Submit Manuscript

Contact Us